Department of Radiation Oncology
4921 Parkview Place, Campus Box 8224
81 articles with Washington University
Here’s a look at 10 of the more compelling research stories of the year.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The test developed at Washington University, which is likely years away from clinical use, tests for amyloid in the blood—if the blood amyloid levels are very low, it’s possible that the individual may have amyloid plaques in the brain.
Collaboration Achieves First Significant Milestone with Successful Execution of Technology Transfer
Cellect Begins Collaboration with Washington University in Preparation for First U.S. Clinical Trial Using Cellect's ApoGraft™ for Bone Marrow Transplantations
The Collaboration will be led by Renowned Cell and Gene Therapy Experts Dr. John DiPersio and Dr. Mark Schroeder with Advisory support to Cellect by Prof. Negrin of Stanford and Dr. Cutler of Harvard Medical School
10/19/2018There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Bristol-Myers Squibb has appointed Christopher Boerner to replace Murdo Gordon, who left the company on August 3. Boerner will take on the positions of executive vice president and chief commercial officer, effective immediately.
Mallinckrodt to fund up to $10 million in collaborative research programs over five years to focus on rare diseases
Q Biomed Inc. Extends its Exclusive Option Agreement With Washington University in St. Louis for a Novel Companion Biomarker for Monitoring Glaucoma and Initiates a Clinical Study
Q BioMed Inc. is pleased to announce that it is extending its option agreement with Washington University in St. Louis.
Specialist Direct, Inc. and Washington University School of Medicine in St. Louis collaborate to provide Telepathology for Organ Procurement Organizations
Polaris Group Announces Treatment of First Patient in a Phase 2 Study of ADI-PEG 20 Plus Gemcitabine and Docetaxel for Soft Tissue Sarcoma
Polaris Group announced that the first patient has been dosed in a phase 2 trial of ADI-PEG 20 in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma.
Researchers at Washington University Report DiviTum Can Evaluate the Biologic Activity of Blockbuster Breast Cancer Drug Ibrance After Just Two Weeks
Led by Dr Cynthia Ma, the study investigated 50 women with breast cancer treated with standard endocrine therapy in combination with Ibrance prior to surgery.
Sunesis Announces Presentation Of Updated Results From Washington University-Sponsored Phase I/Cohort Expansion Trial Of Vosaroxin Plus Azacitidine In Patients With MDS At The European Hematology Association Annual Meeting
Canopy Biosciences Licenses Novel Gene Editing Technology From Washington University And Johns Hopkins University
MediBeacon Collaborates With Washington University In $1.1 Million Grant For Groundbreaking Research In Global Health And Development
Washington University Acquires ViewRay Incorporated Research System To Investigate MRI-Guided Linac Capabilities
Centene Corporation Partners With Washington University In St. Louis And Duke University To Launch The Envolve Center For Health Behavior Change
Rebiotix And Washington University Treat First Patient With Urinary Tract Infection Utilizing Investigational RBX2660 To Potentially Reverse Multidrug Resistant Organisms
Sunesis Announces Presentation Of Results From Washington University Sponsored Phase 1/2 Trial Of Vosaroxin In MDS And VALOR Analysis Of Baseline Safety Predictors At Washington University Annual Meeting